Results 221 to 230 of about 465,548 (350)

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Clinical Cancer Research, 2015
Hyon-Zu Lee, V. Kwitkowski, P. D. Del Valle, M. S. Ricci, H. Saber, B. Habtemariam, J. Bullock, E. Bloomquist, Yuan Li Shen, Xiao-Hong Chen, Janice Brown, Nitin Mehrotra, Sarah E Dorff, R. Charlab, Robert C. Kane, E. Kaminskas, R. Justice, A. Farrell, R. Pazdur   +18 more
semanticscholar   +1 more source

Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones

The Journal of Dermatology, EarlyView.
ABSTRACT Mycosis fungoides (MF) is a unique type of lymphoma with an excellent prognosis presenting with a wide variety of clinical and histological findings. Recent sophisticated research techniques have revealed that very slow changes in the clinical and histological pictures of one patient over time are due to intratumoral heterogeneity.
Ryoma Honda, Toshihisa Hamada, Makoto Sugaya   +2 more
wiley   +1 more source

CD30+ T-cell lymphoma following Chimeric Antigen Receptor T-cell therapy (CART-cell therapy): Diagnostic uncertainty in a postimmunotherapy setting. [PDF]

JAAD Case Rep
McClanahan M, Stokes M.
europepmc   +1 more source

A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

British Journal of Haematology, 2015
F. Foss, R. Advani, M. Duvic, K. Hymes, T. Intragumtornchai, A. Lekhakula, O. Shpilberg, A. Lerner, R. Belt, E. Jacobsen, G. Laurent, D. Ben-yehuda, M. Beylot‐Barry, U. Hillen, P. Knoblauch, G. Bhat, S. Chawla, L. F. Allen, B. Pohlman   +18 more
semanticscholar   +1 more source

Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype. [PDF]

J Cutan Pathol
Planella-Fontanillas N, Molina-Alvarez A, Colomo-Saperas L, Rovira R, Gonzàlez-Farré M, Barranco-Sanz C, Calvo X, Nadal-Pellisé C, Gallardo F, Pujol RM.   +9 more
europepmc   +1 more source

Breast Lymphoma: Rare Mimicker of Breast Cancer. [PDF]

Indian Dermatol Online J
Dharia AM, Jangid KM, Tambe SA, Mahobia S.   +3 more
europepmc   +1 more source

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

Journal of Clinical Oncology, 2015
P. Barr, Hongli Li, C. Spier, D. Mahadevan, M. LeBlanc, Mansoor Ul Haq, Bryan D. Huber, C. Flowers, N. Wagner-Johnston, S. Horwitz, R. Fisher, B. Cheson, Sonali M. Smith, B. Kahl, N. Bartlett, J. Friedberg   +15 more
semanticscholar   +1 more source

Novel anti-ITGA4 monoclonal antibody induces cell death via large pore formation in NK/T-cell lymphoma cells. [PDF]

Sci Rep
Takeuchi S, Ito Y, Matsuoka S, Abe M, Tsurui H, Horimoto Y, Fukuhara T, Hirano T, Mizutani N, Ito T, Hatano R, Nakao A, Terao Y, Kitade M, Hamano Y, Takamatsu H, Matsuoka H, Nakatsura T, Yagita H, Okumura K, Itakura A.   +20 more
europepmc   +1 more source

PLoS One [PDF]

, 2012
Alles, J., Barth, S., Cogliatti, S., Dueck, A., Grasser, F., Imig, J., Meister, G., Motsch, N., Reineke, T., Renner, C., Tinguely, M., Zhu, J.   +11 more
core   +1 more source

Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review

Therapeutic Advances in Hematology, 2015
A. Sawas, D. Radeski, O. O’Connor
semanticscholar   +1 more source